Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03333174 · ClinicalTrials.gov registry record · NA
Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 3
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03333174 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 25 participants.
The verdict
NCT03333174, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
To determine if servo-controlled oxygen environment is associated with reduction in (a) bradycardia events, (b) hypoxemic time, (c) bradycardia time, (d) apneic episodes
Interventions
- DIAGNOSTIC_TEST Cardiorespiratory monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-04-09 |
| Est. Completion | 2021-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03333174
The ClinicalTrials.gov registry entry for NCT03333174 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiorespiratory monitoring is the first listed.
NCT03333174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03333174 about?
NCT03333174 is a clinical study titled "Prematurity Related Ventilatory Control (PRE-VENT) - Specific Aim 3". To determine if servo-controlled oxygen environment is associated with reduction in (a) bradycardia events, (b) hypoxemic time, (c) bradycardia time, (d) apneic episodes
What is the current status of trial NCT03333174?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-04-09. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT03333174?
The interventions under investigation include: Cardiorespiratory monitoring (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03333174?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.